Breakthrough in Pet Diagnostics: Seamaty's New Automated PCR Instrument

In recent years, with the rapid growth of the pet industry and continuous improvements in veterinary medical services, pet health has become a focal point of concern. Infectious diseases, in particular, which spread quickly and have significant impacts, weigh heavily on the minds of pet owners. Since pets can't communicate their symptoms, early and accurate disease diagnosis is crucial for effective treatment. But how can we ensure early detection and timely treatment?

In clinical practice, the main methods for diagnosing pet diseases include biochemical testing, immunoassay, and nucleic acid testing. Nucleic acid testing, known for its high sensitivity and specificity, significantly shortens the detection window for infectious diseases and is considered the "gold standard" for diagnosing pet infections.

As a leading brand in the field of in vitro diagnostics for pets, Seamaty is committed to providing veterinarians with more efficient and accurate diagnostic tools. Building on years of technical expertise and experience, Seamaty proudly introduces its new fluorescent quantitative PCR system: the VQ1 Fully Automated Nucleic Acid Detection System.

The VQ1 requires only one step for sample addition and delivers results in just 40 minutes. Designed specifically for the veterinary diagnostic market, it features fully enclosed microfluidic reagent cartridges preloaded with lyophilized reagents, eliminating the need for complex liquid handling steps. The system is easy and safe to operate, featuring an independent temperature control module capable of rapid temperature changes (10℃/s), completing the entire qPCR process within 40 minutes. This technology significantly supports fast and accurate diagnosis of pet diseases, providing comprehensive, accurate, and convenient diagnostic solutions for veterinary hospitals and breeding centers.

Product Advantages:

1. Fully Automated Operation, Worry-Free

• Automated extraction, purification, and amplification with less than 30 seconds of manual handling.
• Single-step sample addition with sample-in, results-out functionality, operable by non-specialist personnel.

2. Highly Efficient Testing, Comprehensive Coverage

• Ultrasonic lysis and mixing, doubling efficiency and speed, delivering results within 40 minutes.
• Broad compatibility with multiple test panels, supporting up to 36 simultaneous tests.

3. Laboratory Gold Standard, Ultra-Precise

• Magnetic bead extraction combined with qPCR detection ensures laboratory-grade accuracy.
• Active heat-sealing technology prevents aerosol contamination, enhancing detection specificity.
• Sequential sample loading eliminates air bubbles in reaction wells, ensuring more precise results.

4. Fully Enclosed Reagent Cartridges, Ultra-Safe

• Microfluidic reagent cartridges integrate sample extraction, purification, system construction, and nucleic acid amplification.
• Independent zoned temperature control and mobile lighting technology ensure faster temperature changes and signal acquisition.
• Fully enclosed cartridges prevent contamination.

5. Superior Reagent Performance, Ultra-Convenient

Advanced high-temperature resistant lyophilization technology allows for ambient storage and transportation, with a shelf life of up to one year.

Conclusion

The launch of Seamaty's VQ1 Fully Automated Nucleic Acid Detection System marks a significant advancement in pet diagnostics. With its user-friendly design, rapid and precise testing capabilities, and comprehensive safety features, the VQ1 provides a powerful tool for veterinary professionals. This innovative system ensures early detection and treatment of infectious diseases in pets, ultimately contributing to better pet health and peace of mind for pet owners.